Jean-Louis Corhay

[Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease].

18F-FDG PET imaging in assessing exudative pleural effusions.

[Exacerbations in COPD: a burden to curtail].

Granulocyte chemotactic activity in exhaled breath condensate of healthy subjects and patients with COPD.

[Clinical study of the month: the TORCH study (TOwards a Revolution in COPD Health)].

Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.

Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.

[Pulmonary rehabilitation in chronic obstructive pulmonary disease].

[The UPLIFT study (Understanding Potential Long-term Impacts on Function with Tiotropium)].

Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD.

[Medication of the month. Indacaterol (Onbrez Breezhaler) and chronic obstructive pulmonary disease].

Should we exclude elderly patients with chronic obstructive pulmonary disease from a long-time ambulatory pulmonary rehabilitation programme?

[COPD: genetics and environmental interactions].

Diagnostic value of neurotrophin expression in malignant pleural effusions.

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.

A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.

Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction.